AstraZeneca has announced the appointment of Stavros Dogiakos as the new President and CEO of AstraZeneca Greece & Cyprus. Dogiakos will assume his responsibilities on September 1st, 2026. He will succeed Elena Chouliara in the role, marking a significant leadership transition for the company in the region. The announcement signals AstraZeneca’s continued commitment to the Greek and Cypriot markets. Details regarding Dogiakos's previous experience and AstraZeneca’s future strategy under his leadership were not immediately available. This appointment is expected to drive continued growth and innovation within AstraZeneca's operations in Greece and Cyprus. The company anticipates a smooth handover from Chouliara to Dogiakos.